|
Hot Pursuit
09-Oct-21
|
|
|
|
|
|
|
Gland Pharma receives tentative approval for sugammadex injection
|
Gland Pharma on Friday announced that it received tentative approval from the United States Food and Drug Administration (USFDA) for sugammadex injection.
|
|
|
Sugammadex injection is a single-dose vial, bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Bridion Injection of Merck Sharp & Dohme Corp. The injection is used to reverse the effects of the muscle relaxants Rocuronium Bromide and Vecuronium Bromide given to patients during surgery.
According to IQVIA, sugammadex injection had US sales of approximately $615 million for twelve months ending in April 2021. Gland Pharma said it will launch the product through its marketing partner on receipt of final approval.
Shares of Gland Pharma fell 0.82% to close at Rs 3,851.55 on Friday.
Hyderabad-based Gland Pharma is one of the largest and fastest growing injectable-focused companies. It operates primarily under a business to business (B2B) model and it engaged in development, manufacturing and marketing of complex injectables. The company's net profit jumped 11.81% to Rs 350.65 crore on 30.50% increase in revenue from operations to Rs 1,153.90 crore in Q1 FY22 over Q1 FY21.
|
|
Previous News |
Gland Pharma fixes record date for final dividend
(
Market Beat
-
Reports
22-May-24
19:56
)
|
|
Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter
(
Results
-
Announcements
06-Aug-24
17:16
)
|
|
Stock alert: Indus Towers, Gland Pharma, Advanced Enzyme, DMart, Sapphire Foods
(
Market Commentary
-
Stock Alert
20-Jun-24
08:50
)
|
|
Gland Pharma consolidated net profit rises 144.56% in the March 2024 quarter
(
Results
-
Announcements
23-May-24
07:36
)
|
|
Gland Pharma
(
Results
-
Analysis
08-Aug-23
11:02
)
|
|
Gland Pharma rallies on USFDA nod for breast cancer drug
(
Hot Pursuit
-
08-Apr-24
13:18
)
|
|
USFDA conducts surprise inspection of Gland Pharma's Dundigal facility
(
Corporate News
-
25-Jul-24
13:49
)
|
|
Volumes soar at Axis Bank Ltd counter
(
Hot Pursuit
-
09-Apr-24
11:00
)
|
|
Gland Pharma Ltd spurts 2.01%, gains for third straight session
(
Hot Pursuit
-
27-Dec-23
13:05
)
|
|
Gland Pharma consolidated net profit declines 72.48% in the March 2023 quarter
(
Results
-
Announcements
19-May-23
07:25
)
|
|
Gland Pharma tumbles after Q4 PAT declines over 72% YoY
(
Hot Pursuit
-
19-May-23
09:37
)
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|